NordShield® has created a unique antimicrobial product – sustainably produced, nontoxic and renewable. NordShield can be applied to any given surface, protecting against viruses, bacteria and mold.
Nordic BioTech Group, branded as NordShield®, a company established in Finland in 2016, has developed a revolutionary antimicrobial product, called NordShield. It is a novel non-toxic, biodegradable and renewable product on the market that protects against viruses, bacteria and mold. NordShield is of natural origin and can be used on surfaces, such as on fabrics, medical equipment or other surfaces. Research confirms the virucidal efficacy against MVA (Modified vaccina virus Ankara), used as a substitute virus for testing against enveloped viruses, including SARS, MERS and Human corona viruses.
NordShield was commercialized after more than 12 years of research and development. It revolutionizes the way antimicrobials work by providing a natural alternative to hazardous antimicrobial substances. “Our product forms a bioactive molecular net on treated surfaces, providing a safe, non-toxic and long-lasting protection against viruses, bacteria and mold,” explains the company’s CEO Kristoffer Ekman. By providing a natural alternative, NordShield can help to minimize the use of harmful substances and thus create a safer and more environmentally friendly living environment for us all.
While not specifically tested for the effectiveness against 2019-nCoV coronavirus, research conducted by Dr. Brill + Partner, Institute for Hygiene and Microbiology indicates that NordShield could be useful in the fight against the current pandemic. The product would be especially helpful when treating hospital textiles and medical safety gear such as face masks. “We believe that in the future, our innovation will be able to help slow-down and reduce the spreading of global epidemics,” says Kristoffer Ekman.
To aid the confining of the pandemic, Nordic BioTech Group has offered its water based antimicrobial fiber application free of charge to the European authorities. “The seriousness of the pandemic and the effect it has on each and every one of us, made the decision to offer our help self-evident”, says Kristoffer Ekman.
Nordic Biotech Group has partnered with organizations around the world – including Finland, Sweden, Germany, France, China and Japan – to develop applications for NordShield within both the medical, fiber and personal care industries. While continuing the work with its current partners, Nordic BioTech Group is continuing its expansion globally.
Nordic BioTech Group, branded as NordShield®, is the world leading supplier of natural based antimicrobial solutions. NordShield® as a commercial technology was born after more than 10 years of researching, developing, testing, verifying, certifying and patenting. The result is a revolutionary technology with a unique combination of naturality, power and efficacy. This highly scalable technology enables the strongest protection with highest naturality - a creation as unique and powerful as nature and one that leaves nothing but goodness behind. Founded in 2016 and headquartered in Espoo, Finland, NordShield® is disrupting the field of antimicrobial technology through a durable, natural based and safer alternative for antimicrobial protection that can be utilised across applications and industries.
For more information, visit www.nordshield.com
Contact to NordShield®:
Emmi Kavander, Chief Communications Officer / NordShield®
This document may contain statements related to Nordic Biotech Group Oy’s future business and financial performance and future events or developments that may constitute forward-looking statements. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of any such statements. Nordic Biotech Group neither intends, nor assumes any obligation, to update or revise these statements in light of developments which differ from those anticipated. Nordic BioTech Group Oy and its affiliates are not liable for any decision made or action taken in conjunction with the information and/or statement in this document or for any related damage.
This document contains statements that are only applicable within the European Union and this document is intended only for distribution within the European Union. Nordic BioTech Group Oy does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of any such statements and is not liable for any such statements.